scispace - formally typeset
F

Falk Hiepe

Researcher at Humboldt University of Berlin

Publications -  325
Citations -  18996

Falk Hiepe is an academic researcher from Humboldt University of Berlin. The author has contributed to research in topics: Lupus erythematosus & Antibody. The author has an hindex of 64, co-authored 310 publications receiving 15902 citations. Previous affiliations of Falk Hiepe include University of Tokyo & German Center for Neurodegenerative Diseases.

Papers
More filters
Journal ArticleDOI

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

Martin Aringer, +63 more
TL;DR: To develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism and the American College of Rheumatology (ACR).
Journal ArticleDOI

Competence and competition : the challenge of becoming a long-lived plasma cell

TL;DR: Studies of the biology of plasma cells reveal a mechanism of intriguing simplicity and elegance that focuses memory provided by plasma cells on recently encountered pathogens while minimizing the 'fading' of memory for pathogens encountered in the distant past.
Journal ArticleDOI

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

Gerald B. Appel, +98 more
TL;DR: Although most patients in both treatment groups experienced clinical improvement, the study did not meet its primary objective of showing that MMF was superior to IVC as induction treatment for lupus nephritis.
Journal ArticleDOI

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

Martin Aringer, +66 more
TL;DR: These new classification criteria for systemic lupus erythematosus have excellent sensitivity and specificity, and were developed using rigorous methodology with multidisciplinary and international input.
Journal ArticleDOI

Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus.

TL;DR: There are profound abnormalities in the various B cell compartments in SLE that respond differently to immunosuppressive therapy, and CD27high plasma cells showed a similar degree of somatic hypermutation, but preferentially employed VH4 family members.